BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

MANN, V. M., COOPER, J. M., KRIGE, D., DANIEL, S. E., SCHAPIRA, A. H. V., MARSDEN, C. D.·1992·Brain
DOI 10.1093/brain/115.2.333

Cited by (345)

Items 301–345 of 345

  1. Loss of PINK1 or Parkin Function Results in a Progressive Loss of Mitochondrial Function
    Jan‐Willem Taanman, Margherita Protasoni · 2017 · Elsevier eBooks
  2. Mitochondrial Involvement in Neurodegenerative Dementia
    Laura Bonanni, Valério Frazzini, Astrid Thomas, MARCO C. ONOFRJ · 2015 · Wiley eBooks
  3. Cinnarizine, a Calcium Channel Blocker, Partially Prevents the Striatal Dopamine Decline and Loss of Nigral Dopamine Neurons in the Lactacystin-Induced Rat Model of Parkinson’s Disease
    Elżbieta Lorenc‐Koci, Tomasz Lenda, Jolanta Konieczny, Danuta Jantas, Helena Domin · 2025 · International Journal of Molecular Sciences
  4. Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations
    Ana Lizeth Padilla, José Luis Lanciego, Miquel Vila, Fernando de Castro, David Pozo, Fernando Rodrı́guez de Fonseca, Antonia Serrano, Javier Sáez‐Valero, Lucı́a Núñez, Carlos Villalobos et al. · 2026 · Acta Pharmaceutica Sinica B
  5. Chemo- and Mechano-Induced Reactions of Vascular Smooth Muscles in Rats with Chronic Insufficiency of Cerebral Dopamine: Effect of Co-Enzyme Q10
    Sergey A. Talanov, Mikhail N. Tkachenko, Olga V. Bazilyuk, Lyubov. G. Stepanenko, Vadim F. Sagach · 2009 · Neurophysiology
  6. Mitochondrial Dysfunction and Neurodegenerative Diseases
    Michael Lin, M. Flint Beal · 1998 · Springer eBooks
  7. Neuroprotection in Parkinson's Disease: a Multi-directional Genetic Strategy for Maximum Protection of Dopaminergic Neurons against Parkinsonian Toxicity
    Mossa Gardaneh, Yasin Panahi, Sahar Shojaei · 2010 · Journal of Medical Hypotheses and Ideas
  8. Parkinson's disease: molecular aspects and prospective neuroprotective and restorative therapies
    Hernández Montiel, Hebert Luís Hernández-Montiel · 2006 · Archivos de Neurociencias
  9. Mitochondrial Therapeutic Approaches in Parkinson’s Disease
    A. Raquel Esteves, Diana Filipa Silva, Maria G-Fernandes, Rui Gomes, Sandra M. Cardoso · 2016 · Springer eBooks
  10. Rotenone Model for Parkinson’s Disease
    Ranjita S. Betarbet, J. Timothy Greenamyre · 2007 · CRC Press eBooks
  11. Mitochondria and Parkinson’s Disease
    Russell Howard Swerdlow · 2001 · Humana Press eBooks
  12. Mitochondrial Diseases: Noninvasive Approaches
    D.J. Taylor, G. K. Radda · 1994 · Current topics in bioenergetics
  13. Therapeutic and Diagnostic Agents for Parkinson's Disease
    Raymond G. Booth, John L. Neumeyer, Ross J. Baldessarini · 2010 · Burger's Medicinal Chemistry and Drug Discovery
  14. Excitoxicity and excitatory amino acid antagonists in chronic neurodegenerative diseases
    Chrysanthy Ikonomidou, Lechosław Turski · 2005 · Cambridge University Press eBooks
  15. Oxidative stress
    Mario E. Götz, Gabriella Künig, Peter Franz Riederer, Moussa B. H. Youdim · 1996 · Elsevier eBooks
  16. Pathogenesis of Parkinson’s disease: iron and mitochondrial DNA deletion
    Yoshikuni Mizuno, Hideki Mochizuki, Katsunori Nishi, S Ikebe, Nobutaka Hattori, Y. Hattori-Nakagawa · 1993 · Key topics in brain research
  17. Mitochondrial dysfunction in diabetes mellitus
    Christen M. Anderson · 1999 · Drug Development Research
  18. Mitochondrial Involvement in Neurodegeneration and Aging
    Alicia M. Pickrell · 2012
  19. Efeito do difenil disseleneto sobre o déficit energético e alterações na morfologia e conteúdo mitocondriais induzidos pelo metilmercúrio no córtex cerebral de camundongos
    Roberta de Paula Martins · 2012
  20. Molecular Pathways of Mitochondrial Dysfunction in Neurodegeneration: the Paradigms of Parkinson's and Huntington's Diseases
    Ana Cristina Rego, Sandra M. Cardoso, Catarina Resende Oliveira · 2007 · Springer eBooks
  21. This student paper was written as an assignment in the graduate course Free Radicals in Biology and Medicine
    Garry R. Buettner, Larry W. Oberley, Douglas R. Spitz, Frederick E. Domann · 2003
  22. A Get‐Together to Tear It Apart
    Gian‐Luca McLelland, Edward A. Fon · 2015 · Wiley eBooks
  23. The bipyridyl herbicide paraquat-induced toxicity in human neuroblastoma SH-SY5Y cells: relevance to dopaminergic pathogenesis
    Wonsuk Yang · 2006 · OakTrust (Texas A&M University Libraries)
  24. Oxygen toxicity and mitochondrial metabolism.
    Jian Li · 2003
  25. Mitochondrial Mutations in Parkinson's Disease and Dystonias
    David K. Simon · 2003 · Elsevier eBooks
  26. Loss of Mortalin Function in Parkinson’s Disease-Supporting the Mitochondrial Pathway of Neurodegeneration
    Lena F. Burbulla, Rejko Krüger · 2012 · Springer eBooks
  27. Neuronal and Mitochondrial Protection in Chronic Parkinsonism
    Gaurav Patki · 2010
  28. Estudo do efeito dos metabólitos do benzeno e tolueno sobre as mitocôndris cerebrais e hepáticas de ratos
    George Emilio Barreto · 2005 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  29. EFECTO DE LA ADMINISTRACIÓN CRÓNICA DE LEVODOPA SOBRE LA ACTIVIDAD FUNCIONAL DE LA VÍA NIGROESTRIADA EN MACACOS CON PARKINSONISMO INDUCIDO POR MPTP
    Mario Riverol Fernández · 2010
  30. Einfluss von L-Dopa und der Stimulation des Nucleus subthalamicus auf qualitative und quantitative Bewegungsparameter bei Parkinson- Patienten
    P. Hartung · 2010
  31. Understanding the mechanisms underlying the neuroprotective role of calorie restriction in Parkinson’s Disease
    Jacqueline A. Bayliss · 2017 · Figshare
  32. Neurotransmission, Oxidative Stress, and Coexistence of Neurotransmitters in Parkinson's Disease
    G. Ali Qureshi · 2007 · Elsevier eBooks
  33. Therapeutic Effects of Natural Antioxidant on Neurodegenerative Disease
    Fabiola Domínguez, Hermelinda Salgado‐Ceballos, Eva González-Trujano, Sergio Torres-Castillo, Sandra Adela Orozco-Suárez · 2011
  34. The nigrostriatal toxicity of beta-carbolines
    LeBlanc, Gregory Andrew · 1998 · Library and Archives Canada (Government of Canada)
  35. Über die Tumorigenität und den potenziellen Nutzen ausgewählter Stammzellersatztherapien in dem 6-Hydroxydopamin-Parkinsonmodell der Ratte
    Charles-Arnold Timäus · 2012
  36. Systematic analysis of rare variants in mitochondrial function-associated genes for autosomal-dominant Parkinson’s disease in a Chinese population
    Yongping Chen, Xiaojing Gu, Ruwei Ou et al. · 2020
  37. Etablierung eines Tiermodells der Parkinson-Krankheit auf der Grundlage von mitochondrialer Komplex-I Hemmung
    Mesbah Alam · 2004
  38. How T-cells influence microglia to form a feedback loop that accelerates disease progression in Parkinson’s disease
    Floris C. Loeff · 2011 · Utrecht University Repository (Utrecht University)
  39. Therapeutic and Diagnostic Agents for Parkinson's Disease
    Ola M. Ghoneim, Raymond G. Booth · 2021 · Burger's Medicinal Chemistry and Drug Discovery
  40. Faculty Opinions recommendation of Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control.
    Sharon A. Tooze, Christopher A. Lamb · 2014 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  41. Parkinson's disease
    William James Mutch · 1995 · Reviews in Clinical Gerontology
  42. Platelets in Neurodegenerative Diseases
    Ilaria Canobbio, Mauro Torti, Gianni Francesco Guidetti · 2025 · Springer eBooks
  43. Potentialisation des effets de composés phénoliques combinés de l’huile d’olive : étude des transformations rédox : application dans les maladies neurodégénératives
    Morgane Lambert de Malezieu · 2019 · theses.fr (ABES)
  44. Mécanismes de compensation dans la maladie de Parkinson : approches comportementale, pharmacologique, de neuro-imagerie et immunohistochimique chez le singe intoxiqué au MPTP après récupération des symptômes moteurs
    Sara Neumane · 2011
  45. Molecular Mechanisms of Mitochondrial Transport in Neurons
    Miloš Babić · 2015 · UA Campus Repository (The University of Arizona)